Regulatory B Cells: Role in Type 1 Diabetes

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• Regulatory B cells (Bregs) possess anti-inflammatory properties and suppress autoimmunity through cytokine secretion and cell contact.
• Various Breg subsets exist, often characterized by immune markers and cytokine production, with IL-10 secretion being a hallmark.
• The role and frequency/function of Bregs in type 1 diabetes (T1D) are not well-established, with limited existing reports.

Purpose of the Study:

• To review the alterations in regulatory B cell frequency and function during the development of type 1 diabetes.
• To synthesize current knowledge on the involvement of Bregs in T1D pathogenesis.
• To discuss findings from both human and animal studies concerning Bregs and T1D.

Main Methods:

• Literature review focusing on regulatory B cells and type 1 diabetes.
• Analysis of studies investigating Breg frequency and function in T1D models and patients.
• Synthesis of data from human and animal research.

Main Results:

• Limited reports suggest potential impairments in Breg frequency or function in individuals with type 1 diabetes.
• The precise mechanisms by which Bregs influence T1D development require further elucidation.
• Existing research highlights the complexity and heterogeneity of Breg subsets involved in autoimmune diseases.

Conclusions:

• Regulatory B cells play a significant role in immune regulation and autoimmunity, with implications for type 1 diabetes.
• Further research is needed to fully understand the functional and frequency alterations of Bregs in T1D.
• Investigating Breg subsets may offer novel therapeutic targets for type 1 diabetes treatment.